Hain Celestial(HAIN) - 2026 Q1 - Quarterly Results
2025-11-07 12:12
Financial Performance - Net sales for the fiscal first quarter were $368 million, a decrease of 7% year-over-year, with organic net sales down 6%[6] - The net loss for the quarter was $21 million, compared to a net loss of $20 million in the prior year, with an adjusted net loss of $7 million versus $4 million in the prior year[6] - Net sales for Q1 FY26 were $367,883, a decrease of 6.8% compared to $394,596 in Q1 FY25[35] - The company reported a net loss of $20,625 in Q1 FY26, compared to a net loss of $19,663 in Q1 FY25[39] - The adjusted net loss for Q1 FY26 was $7,242, compared to an adjusted net loss of $3,808 in Q1 FY25[45] - North America net sales decreased by 11.8% to $203,920 in Q1 FY26, while international sales increased slightly by 0.3% to $163,963[48] Profitability Metrics - The gross profit margin was 18.5%, reflecting a 220-basis point decrease from the prior year, while adjusted gross profit margin was 19.5%, a 120-basis point decrease[6] - Adjusted EBITDA was $20 million, down from $22 million in the prior year, with an adjusted EBITDA margin of 8.3% compared to 5.4% in the prior year[11] - Adjusted EBITDA for Q1 FY26 was $19,732, reflecting an 11.8% decrease compared to $22,375 in Q1 FY25[41] - The company experienced a decrease in gross margin to 18.5% in Q1 FY26 from 20.7% in Q1 FY25[41] - Adjusted EBITDA in the North America segment increased by 37% to $17 million, driven by productivity savings and reduced SG&A expenses[11] Cash Flow and Debt - Free cash flow was negative $14 million, an improvement from negative $17 million in the prior year[13] - Cash and cash equivalents at the end of Q1 FY26 were $47,886, down from $56,853 at the end of Q1 FY25[39] - Free cash flow for Q1 FY26 was $(13,707), an improvement from $(16,544) in Q1 FY25[54] - Total debt at the end of the quarter was $716 million, up from $705 million at the beginning of the fiscal year[13] - Total debt as of September 30, 2025, was $716,210, with net debt at $668,324[56] - Long-term debt, less current portion, increased to $708,563 as of September 30, 2025, from $697,168 as of June 30, 2025[37] Sales Performance by Segment - North America segment net sales were $204 million, down 12% year-over-year, while International segment net sales were $164 million, flat year-over-year[8] - Organic net sales in North America decreased by 7%, primarily due to volume softness in snacks, while International organic net sales decreased by 4% driven by lower sales in baby & kids[9][12] - Organic net sales for Q1 FY26 were $341,495, down 5.8% from $362,517 in Q1 FY25[50] - The company reported a decline in organic net sales across all categories, with snacks down 17.2% and baby & kids down 9.5% in Q1 FY26[50] Other Key Metrics - The impact of divestitures and discontinued brands reduced consolidated net sales by $19,828 in Q1 FY26[48] - The impact of foreign currency exchange on consolidated net sales was a gain of $6,560 in Q1 FY26[48] - Total assets decreased to $1,582,899 as of September 30, 2025, from $1,603,278 as of June 30, 2025[37]
Agrify (AGFY) - 2025 Q3 - Quarterly Report
2025-11-07 12:11
Acquisitions and Brand Development - RYTHM's acquisition of the Señorita brand in November 2024 introduced hemp-derived THC beverages, which quickly gained acclaim, winning The High Times Cannabis Cup within a year[168]. - The company reported cash consideration of $5.1 million for acquiring MC Brands, which includes the incredibles brand, and $50.0 million for acquiring VCP, which includes multiple intellectual property rights[170][171]. - RYTHM's hemp-derived beverages are available in eleven U.S. states and Canada, with plans for further expansion into premier on-premises destinations[165]. - The company has entered into distribution agreements to expand its hemp-derived beverage products in domestic markets during the first nine months of 2025[174]. - The Señorita brand offers four flavors of THC beverages, including classic Lime Jalapeño Margarita and Mango Margarita, emphasizing low-sugar and low-calorie options[169]. Financial Performance - Revenue for the three months ended September 30, 2025, was $4.043 million, an increase of $4 million compared to the same period in 2024[196]. - Non-licensing revenue for the three months ended September 30, 2025, was $3.511 million, with $696 thousand attributable to related parties[196]. - Revenue for the nine months ended September 30, 2025, was $6.623 million, an increase of $6.6 million compared to the same period in 2024[197]. - Net loss for the three months ended September 30, 2025, was $10.665 million, compared to a net loss of $18.651 million for the same period in 2024[195]. - Net loss per share attributable to common stockholders for the three months ended September 30, 2025, was $(5.33) compared to $(17.28) for the same period in 2024[195]. - The company reported a net loss of $19.7 million for the nine months ended September 30, 2025, which included $2.5 million related to depreciation and amortization[219]. Costs and Expenses - Cost of goods sold for the three months ended September 30, 2025, was $2.668 million, an increase of $2.6 million compared to the same period in 2024[198]. - Gross profit for the three months ended September 30, 2025, was $1.375 million, representing 34.0% of total revenue[200]. - Selling, general and administrative expenses for the three months ended September 30, 2025, were $10.263 million, an increase of 741% compared to the same period in 2024[202]. - SG&A expenses included $3.1 million attributable to related parties for the three months ended September 30, 2025[202]. - SG&A expenses increased by $17.7 million, or 467%, for the nine months ended September 30, 2025, compared to the same period in 2024[203]. Cash Flow and Financing - Net cash used in operating activities was $20.5 million for the nine months ended September 30, 2025, compared to $6.3 million for the same period in 2024[218]. - Net cash used in investing activities was $55.1 million for the nine months ended September 30, 2025, primarily due to the acquisition of MC Brands and VCP[221]. - Net cash provided by financing activities was $80.0 million for the nine months ended September 30, 2025, resulting from proceeds from May and August 2025 Notes[222]. - As of September 30, 2025, the company had cash and cash equivalents totaling $35.6 million[212]. Business Operations and Strategy - The company exited the Extraction Business on March 30, 2025, which previously provided innovative cultivation and extraction solutions for the cannabis industry[166]. - RYTHM's proprietary Agrify Vertical Farming Units (VFUs) were sold prior to the sale of the Cultivation Business on December 31, 2024, enabling high-quality product production[175]. - RYTHM's co-manufacturing arrangements are designed to ensure continuity of supply and minimize transportation costs, with ongoing efforts to secure additional facilities[172]. - The company recognizes the imprecision in estimating product demand, particularly for new products, which may impact its ability to satisfy market demand[173]. Interest and Liabilities - Interest expense, net was $1.1 million for the three months ended September 30, 2025, compared to $38 thousand for the same period in 2024, reflecting a 2884% increase due to a $50 million principal increase under Convertible Notes[205]. - The change in fair value of warrant liabilities increased by $14.4 million, or 96%, during the three months ended September 30, 2025, compared to the same period in 2024[207]. Accounting and Reporting - Recently issued accounting pronouncements are detailed in Note 1 of the unaudited condensed consolidated financial statements[227]. - New accounting pronouncements not yet adopted are also included in Note 1 of the unaudited condensed consolidated financial statements[228]. - As a "smaller reporting company," the company is not required to provide market risk disclosures[229].
Fulgent Genetics(FLGT) - 2025 Q3 - Quarterly Results
2025-11-07 12:10
Financial Performance - Revenue for Q3 2025 was $84.1 million, representing a 17% year-over-year growth[5] - GAAP loss for Q3 2025 was $6.6 million, or ($0.21) per share; Non-GAAP income was $4.5 million, or $0.14 per share[6] - GAAP gross profit was $35.5 million, with a GAAP gross margin of 42.2%; Non-GAAP gross profit was $37.2 million, with a Non-GAAP gross margin of 44.3%[5] - Revenue for Q3 2025 was $84,069,000, a 17.1% increase from $71,743,000 in Q3 2024[20] - Gross profit for Q3 2025 was $35,512,000, compared to $26,771,000 in Q3 2024, resulting in a gross margin of 42.2% versus 37.3%[20][23] - Operating loss for Q3 2025 was $15,350,000, an improvement from a loss of $17,079,000 in Q3 2024[20] - Net loss attributable to Fulgent for Q3 2025 was $6,608,000, compared to $14,648,000 in Q3 2024[21] - Non-GAAP income attributable to Fulgent for Q3 2025 was $4,521,000, down from $9,438,000 in Q3 2024[21] - Non-GAAP adjusted EBITDA for Q3 2025 was $708,000, compared to $351,000 in Q3 2024[22] - Total operating expenses for Q3 2025 were $50,862,000, compared to $43,850,000 in Q3 2024[20] - Non-GAAP operating margin for Q3 2025 was -4.2%, improving from -5.8% in Q3 2024[23] Guidance and Future Expectations - Full year 2025 revenue guidance raised to $325.0 million[5] - Full year 2025 EPS guidance updated to a GAAP loss of approximately ($1.70) per share and Non-GAAP income of approximately $0.30 per share[5] - The company expects to receive approximately $106 million in tax refunds prior to December 31, 2025, which may be delayed due to the current government shutdown[7] Assets and Cash Position - Cash, cash equivalents, restricted cash, and investments in marketable securities totaled $787.7 million at the end of Q3 2025[5] - Total assets as of September 30, 2025, were $1,214.6 million, with total stockholders' equity of $1,120.8 million[19] Research and Development - The company is advancing clinical trials for FID-007 and FID-022, demonstrating progress in therapeutic development[4] - Research and development expenses for Q3 2025 were $13,860,000, up from $11,783,000 in Q3 2024[20] Business Transformation - The company aims to transform from a diagnostic business into a fully integrated precision medicine company[12] Selling and Marketing Expenses - Selling and marketing expenses for Q3 2025 increased to $11,642,000 from $9,124,000 in Q3 2024[20]
TaskUs(TASK) - 2025 Q3 - Quarterly Results
2025-11-07 12:09
NEW BRAUNFELS, Texas, November 7, 2025 — TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, today announced its results for the third quarter ended September 30, 2025. "In the third quarter of 2025, we generated record revenue of $298.7 million, a year-over-year growth rate of 17.0%, led by our third quarter in a row of more than 50% growth in AI Services. We also delivered Adjusted EBITDA margins o ...
DraftKings(DKNG) - 2025 Q3 - Quarterly Report
2025-11-07 12:07
Revenue Performance - Total revenue for the three months ended September 30, 2025, was $1,144,019, a 4.4% increase from $1,095,490 in the same period of 2024[226] - Total revenue for the nine months ended September 30, 2025, was $4,065,332, a 20.5% increase from $3,374,927 in the same period of 2024[226] - Revenue increased by $690.4 million, or 20.5%, to $4,065.3 million in the nine months ended September 30, 2025, compared to $3,374.9 million in the same period of 2024[268] Net Loss and Income - Net loss for the three months ended September 30, 2025, was $(256,788), compared to a net loss of $(293,688) in the same period of 2024[226] - Net income (loss) attributable to common stockholders improved by $36.9 million, or 12.6%, to $(256.8) million for the three months ended September 30, 2025, from $(293.7) million in 2024[257] - Net loss decreased by $239.7 million to a net loss of $132.7 million in the nine months ended September 30, 2025, compared to a net loss of $372.4 million in the same period of 2024[280] Unique Payers and Revenue Metrics - Monthly Unique Payers (MUPs) increased by 1.5% in the three months ended September 30, 2025, compared to the same period in 2024[238] - Average Revenue per MUP (ARPMUP) increased by $3 or 3.0% for the three months ended September 30, 2025, compared to the same period in 2024[239] Sportsbook Performance - Sportsbook Handle increased by $1.0 billion, or 10.0%, to $11.4 billion in the three months ended September 30, 2025, from $10.4 billion in the same period of 2024[242] - Sportsbook Handle increased by $3.6 billion, or 10.9%, to $36.8 billion in the nine months ended September 30, 2025, from $33.2 billion in the same period of 2024[242] - Sportsbook Net Revenue Margin decreased by 1.1 percentage points to 5.2% in the three months ended September 30, 2025, from 6.3% in the same period of 2024[243] iGaming and Other Revenue - iGaming revenue for the three months ended September 30, 2025, was $451,300, a 24.9% increase from $361,460 in the same period of 2024[242] - iGaming revenue increased by $89.8 million, or 24.9%, to $451.3 million for the three months ended September 30, 2025, compared to $361.5 million for the same period in 2024[244] - Other revenue for the nine months ended September 30, 2025, was $284,953, a 32.5% increase from $215,055 in the same period of 2024[242] - Other revenue rose by $19.5 million, or 25.3%, to $96.6 million for the three months ended September 30, 2025, primarily due to interest income on customer deposits[245] Cost and Expenses - Cost of revenue increased by $41.6 million, or 5.6%, to $784.1 million for the three months ended September 30, 2025, driven by revenue growth and higher variable expenses[258] - Cost of revenue increased by $366.5 million, or 17.3%, to $2,482.4 million in the nine months ended September 30, 2025, from $2,115.9 million in the same period of 2024[270] - Cost of revenue as a percentage of revenue increased by 0.8 percentage points to 68.5% for the three months ended September 30, 2025, compared to 67.8% in 2024[259] - Sales and marketing expense increased by $40.9 million, or 4.6%, to $937.2 million in the nine months ended September 30, 2025, from $896.3 million in the same period of 2024[273] - Product and technology expense increased by $41.3 million, or 14.5%, to $326.4 million in the nine months ended September 30, 2025, from $285.1 million in the same period of 2024[274] - General and administrative expense decreased by $60.6 million, or 11.1%, to $486.9 million in the nine months ended September 30, 2025, from $547.5 million in the same period of 2024[275] Cash Flow and Financing - Cash and cash equivalents as of September 30, 2025, were $1,228.3 million, sufficient to meet current working capital and capital expenditure requirements for at least twelve months[281] - The cash and cash equivalents at the end of the period increased to $1,708.2 million as of September 30, 2025, compared to $1,156.5 million at the end of the same period in 2024[288] - The company experienced a net increase in cash and cash equivalents of $377.9 million during the nine months ended September 30, 2025, contrasting with a decrease of $466.9 million in the prior year[288] - Cash received from borrowing under the Term B Facility amounted to $588.1 million, contributing to a net cash provided by financing activities of $151.7 million for the nine months ended September 30, 2025, compared to a cash outflow of $71.4 million in 2024[291] - Stock repurchase program authorized up to $1.0 billion, with 8.2 million shares repurchased for $314.0 million in the nine months ended September 30, 2025[287] Interest Expense - The company experienced a significant increase in interest expense, with a net expense of $19.6 million for the three months ended September 30, 2025, compared to an income of $8.3 million in 2024[257] - Interest expense net recorded was $14.5 million in the nine months ended September 30, 2025, compared to $36.3 million of net interest income in the same period of 2024[276] Accounting and Risk - There were no changes to the critical accounting estimates discussed in the 2024 Annual Report, indicating consistency in financial reporting practices[294] - The company has not experienced significant changes in exposure to market risk during the nine months ended September 30, 2025[295] - Commitments and contingencies as of September 30, 2025, are summarized in the unaudited condensed consolidated financial statements[292]
Ubiquiti(UI) - 2026 Q1 - Quarterly Results
2025-11-07 12:07
Exhibit 99.1 UBIQUITI INC. REPORTS FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ~ Revenues of $733.8 million ~ ~ GAAP Diluted Earnings Per Share of $3.43 ~ New York, NY - November 7, 2025 - Ubiquiti Inc. (NYSE: UI) ("Ubiquiti" or the "Company") today announced its financial results for the first quarter ended September 30, 2025. First Quarter Fiscal 2026 Financial Summary Additional Financial Highlight • The Company's Board of Directors declared a $0.80 per share cash dividend payable on November 24, 2025 to ...
Agrify (AGFY) - 2025 Q3 - Quarterly Results
2025-11-07 12:05
Exhibit 99.1 RYTHM, Inc. Reports Third Quarter 2025 Results Recent Developments Management Commentary ROLLING MEADOWS, IL, November 7, 2025 (GLOBE NEWSWIRE) RYTHM, Inc. (Nasdaq: RYM) ("RYTHM" or the "Company") (formerly known as Agrify Corporation), which delivers well-being to consumers through its portfolio of iconic licensed brands and hemp-derived THC products including Señorita THC Margaritas and RYTHM, today announced financial results for the quarter ended September 30, 2025. Third Quarter 2025 Finan ...
News (NWSA) - 2026 Q1 - Quarterly Report
2025-11-07 12:05
Revenue Performance - Total revenues increased by $48 million, or 2%, to $2,144 million for the three months ended September 30, 2025, compared to $2,096 million in the same period of 2024[111] - Circulation and subscription revenues rose by $39 million, or 5%, to $782 million, while advertising revenues decreased by $4 million, or 1%, to $317 million[111] - Revenues at the Dow Jones segment increased by $34 million, or 6%, to $586 million for the three months ended September 30, 2025, driven by higher circulation and subscription revenues[132] - Digital revenues represented 84% of total revenues at the Dow Jones segment for the three months ended September 30, 2025, compared to 82% in the same period of fiscal 2025[132] - Revenues at the Digital Real Estate Services segment increased by $22 million, or 5%, to $479 million for the three months ended September 30, 2025[141] - News Media segment revenues increased by $4 million, or 1%, to $545 million for the three months ended September 30, 2025, driven by a $7 million increase in circulation and subscription revenues[145] Operating Expenses - Operating expenses decreased by $11 million, or 1%, to $941 million for the three months ended September 30, 2025[114] - Selling, general and administrative expenses increased by $44 million, or 5%, to $863 million, primarily due to higher employee and marketing costs[116] Net Income and Earnings - Net income from continuing operations was $150 million, an increase of $1 million, or 1%, compared to $149 million for the same period in 2024[125] - Net income for the three months ended September 30, 2025, was $150 million, an increase of $6 million, or 4%, compared to the same period in fiscal 2025[127] - Net income attributable to noncontrolling interests from continuing operations increased by $7 million, or 23%, for the three months ended September 30, 2025, primarily driven by higher earnings at REA Group[128] Segment Performance - The Digital Real Estate Services segment contributed to revenue growth, driven by higher revenues at Move and REA Group[112] - The Book Publishing segment experienced lower revenues due to decreased book sales, impacting overall performance[112] - Circulation and subscription revenues increased by $32 million, or 7%, to $491 million for the three months ended September 30, 2025, primarily due to growth in digital-only subscriptions[134] - Average daily digital-only subscriptions for The Wall Street Journal increased by 406 thousand, or 11%, to 4,217 thousand for the three months ended September 30, 2025[135] - Digital sales in the Book Publishing segment fell by 9%, representing approximately 23% of consumer revenues in Q3 2025, down from 25% in Q3 2024[143] - Segment EBITDA for Book Publishing decreased by $23 million, or 28%, to $58 million in Q3 2025, primarily due to a $13 million write-off of a customer receivable[144] - Segment EBITDA at the Digital Real Estate Services segment increased by $18 million, or 13%, to $158 million for the three months ended September 30, 2025[141] - Segment EBITDA for News Media increased by $12 million, or 67%, to $30 million in Q3 2025, attributed to cost savings initiatives and higher revenues[146] Cash Flow and Financing - As of September 30, 2025, the Company had cash and cash equivalents of $2.2 billion, with $720 million held by foreign subsidiaries[147][148] - Free cash flow improved to $4 million in Q3 2025, compared to a negative $49 million in the same period of 2024, due to higher cash provided by operating activities[161] - Net cash used in financing activities increased to $179 million in Q3 2025 from $109 million in Q3 2024, influenced by stock repurchases and dividend payments[156][157] - The Company announced a new stock repurchase program on July 15, 2025, authorizing the purchase of up to $1 billion in outstanding Class A and Class B Common Stock[150] - As of September 30, 2025, total borrowings amounted to $1,956 million, with $750 million of undrawn commitments available under the Revolving Facility[162] - HarperCollins entered into a finance leasing arrangement for up to $120 million for equipment, expected to enhance efficiencies[164] - The Equipment Lease will accrue interest based on the Term SOFR plus a margin of 1.475% and can be drawn until June 30, 2028[164] - The total commitments for operating leases as of September 30, 2025, amount to $1,565 million, with $216 million due in less than 1 year[167] Legal and Market Risk - The Company is involved in various legal proceedings, which may adversely affect its financial condition[168] - The Company establishes an accrued liability for legal claims when a loss is probable and can be reasonably estimated[169] - There has been no material change in the Company's assessment of its sensitivity to market risk since the last report[170]
News (NWS) - 2026 Q1 - Quarterly Report
2025-11-07 12:05
Revenue Performance - Total revenues increased by $48 million, or 2%, to $2,144 million for the three months ended September 30, 2025, compared to $2,096 million in the same period of 2024[111]. - Circulation and subscription revenues rose by $39 million, or 5%, to $782 million, while advertising revenues decreased by $4 million, or 1%, to $317 million[111]. - Revenues at the Dow Jones segment increased by $34 million, or 6%, to $586 million for the three months ended September 30, 2025, driven by higher circulation and subscription revenues[132]. - Digital revenues represented 84% of total revenues at the Dow Jones segment for the three months ended September 30, 2025, compared to 82% in the same period of fiscal 2025[132]. - Revenues at the Digital Real Estate Services segment increased by $22 million, or 5%, to $479 million for the three months ended September 30, 2025[141]. - News Media segment revenues increased by $4 million, or 1%, to $545 million for the three months ended September 30, 2025, driven by a $7 million increase in circulation and subscription revenues[145]. Operating Expenses - Operating expenses decreased by $11 million, or 1%, to $941 million for the three months ended September 30, 2025[114]. - Selling, general and administrative expenses increased by $44 million, or 5%, to $863 million, primarily due to higher employee and marketing costs[116]. Net Income and Earnings - Net income from continuing operations was $150 million, an increase of $1 million, or 1%, compared to $149 million for the same period in 2024[125]. - Net income for the three months ended September 30, 2025, was $150 million, an increase of $6 million, or 4%, compared to the same period in fiscal 2025[127]. - Net income attributable to noncontrolling interests from continuing operations increased by $7 million, or 23%, for the three months ended September 30, 2025, primarily driven by higher earnings at REA Group[128]. Segment Performance - The Digital Real Estate Services segment contributed to revenue growth, driven by higher revenues at Move and REA Group[112]. - The Book Publishing segment experienced lower revenues due to decreased book sales, impacting overall performance[112]. - Circulation and subscription revenues increased by $32 million, or 7%, to $491 million for the three months ended September 30, 2025, primarily due to growth in digital-only subscriptions[134]. - Average daily digital-only subscriptions for The Wall Street Journal increased by 406 thousand, or 11%, to 4,217 thousand for the three months ended September 30, 2025[135]. - Digital sales in the Book Publishing segment fell by 9%, representing approximately 23% of consumer revenues in Q3 2025, down from 25% in Q3 2024[143]. - Segment EBITDA for Book Publishing decreased by $23 million, or 28%, to $58 million for the three months ended September 30, 2025, primarily due to a $13 million write-off of a customer receivable[144]. - Segment EBITDA for News Media increased by $12 million, or 67%, to $30 million for the three months ended September 30, 2025, due to cost savings initiatives and higher revenues[146]. - Segment EBITDA at the Digital Real Estate Services segment increased by $18 million, or 13%, to $158 million for the three months ended September 30, 2025[141]. - Total Segment EBITDA for the three months ended September 30, 2025, was $340 million, up $15 million, or 5%, from $325 million in the same period of fiscal 2025[131]. Cash Flow and Financing - Free cash flow improved to $4 million for the three months ended September 30, 2025, compared to a negative $49 million in the same period of 2024, primarily due to higher cash provided by operating activities[161]. - Net cash used in financing activities increased to $179 million for the three months ended September 30, 2025, compared to $109 million in the same period of 2024[156]. - The Company announced a new stock repurchase program on July 15, 2025, authorizing the purchase of up to $1 billion in outstanding Class A and Class B Common Stock[150]. - The Company declared a semi-annual cash dividend of $0.10 per share for Class A and Class B Common Stock, paid on October 8, 2025[153]. Legal and Regulatory Matters - The Company is involved in various legal proceedings, which may adversely affect its financial condition[168]. - Accrued liabilities for legal claims are established when a loss is probable and can be reasonably estimated[169]. - There has been no material change in the Company's assessment of its sensitivity to market risk since the last report[170]. Commitments and Leases - The total commitments for operating leases as of September 30, 2025, amount to $1,565 million, with $216 million due in less than 1 year[167]. - The Company has not experienced significant changes in its commitments since the disclosures in the 2025 Form 10-K[166]. - HarperCollins entered into a finance leasing arrangement for up to $120 million for equipment, expected to enhance efficiencies[164]. - The Equipment Lease will accrue interest based on the Term SOFR plus a margin of 1.475% and may be drawn until June 30, 2028[164].
Canopy Growth(CGC) - 2026 Q2 - Quarterly Results
2025-11-07 12:05
Financial Performance - Consolidated net revenue in Q2 FY2026 was $67MM, a 6% increase compared to Q2 FY2025[3] - Canada adult-use cannabis net revenue in Q2 FY2026 was $24MM, reflecting a 30% increase year-over-year[3] - Canada medical cannabis net revenue in Q2 FY2026 was $22MM, representing a 17% increase compared to Q2 FY2025[3] - International markets cannabis net revenue in Q2 FY2026 was $5MM, a 39% decrease compared to Q2 FY2025 due to supply chain challenges[3] - Total revenue for the three months ended September 30, 2025, was CAD 82,998,000, an increase of 12.5% compared to CAD 73,958,000 in the same period of 2024[30] - Net revenue after excise taxes was CAD 66,683,000, up from CAD 62,991,000, reflecting a growth of 5.4% year-over-year[30] - Total net revenue for the three months ended September 30, 2025, was $66,683, an increase of 6% from $62,991 in 2024[35] - Canadian adult-use cannabis revenue increased by 30% to $23,940 for the three months ended September 30, 2025, compared to $18,388 in 2024[35] Profitability and Loss - Consolidated gross margin in Q2 FY2026 was 33%, a decrease of 200 basis points compared to Q2 FY2025[3] - Operating loss from continuing operations was $17MM in Q2 FY2026, an improvement of 63% compared to Q2 FY2025[6] - Adjusted EBITDA loss was $3MM in Q2 FY2026, compared to a loss of $6MM in Q2 FY2025[6] - Operating loss from continuing operations decreased to CAD 16,894,000 from CAD 45,943,000, indicating improved operational efficiency[30] - The net loss attributable to Canopy Growth Corporation was CAD 1,639,000, a significant reduction from CAD 128,293,000 in the prior year[30] - The gross margin percentage for the cannabis segment decreased to 31% in Q3 2025 from 36% in Q3 2024[38] - Adjusted EBITDA for the three months ended September 30, 2025, was $(3,049), an improvement from $(5,507) in 2024[41] Cash Flow and Liquidity - Year-to-date free cash flow was an outflow of $31MM as of Q2 FY2026, significantly improved from an outflow of $112MM in Q2 FY2025[6] - Cash and cash equivalents increased to CAD 298,058,000 from CAD 113,811,000, showing a strong liquidity position[27] - Cash and cash equivalents at the end of the period increased to $298,058 from $228,416 in the previous year[33] - Net cash provided by financing activities was $194,457 for the six months ended September 30, 2025, compared to $194,717 in 2024[33] - The company reported a net cash used in operating activities of $(28,316) for the six months ended September 30, 2025, down from $(105,632) in 2024[33] - The company experienced a net cash inflow from investing activities of $16,024 for the six months ended September 30, 2025, compared to a net cash outflow of $(31,993) in 2024[33] Balance Sheet and Financial Health - Total assets rose to CAD 1,069,838,000, compared to CAD 917,701,000, reflecting growth in the company's asset base[27] - Total liabilities decreased to CAD 333,825,000 from CAD 430,488,000, indicating improved financial health[27] - Canopy Growth Corporation's total shareholders' equity increased to CAD 736,013,000 from CAD 487,213,000, demonstrating a stronger equity position[27] - The company made prepayments totaling US$50MM against its senior secured term loan in Q2 FY2026[6] - The company reported a basic and diluted loss per share of CAD 0.01 for continuing operations, compared to CAD 1.52 in the same quarter last year[30] - Net loss from continuing operations for the six months ended September 30, 2025, was $43,166, compared to a loss of $260,741 for the same period in 2024, showing a significant improvement[33]